Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile […]
Travere Therapeutics Read More »
We are a group of people with a common goal: to reinvent the food industry — one delicious mouthful at a time. We are here to change the everyday, for everyone and everywhere. With our AI genius, Giuseppe, we have managed to replicate animal products with plants. At NotCo, we replicate the animal products we
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines. We do it to help patients suffering from devastating cancers live longer, better lives. Mission: We are committed to finding answers people with cancer need. We thrive in an atmosphere of passion and tenacity, fueled
SpringWorks Therapeutics Read More »
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno-oncology pipeline includes off-the-shelf, iPSC-derived natural killer
REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological
Revolution Medicines Read More »
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people with cancer live longer. Located in the San Francisco bay area, Arcus Biosciences offers a competitive compensation and benefits package, including aggressive participation in the growth of the company in the
Butterfly Network’s mission is to democratize healthcare by enabling universal access to superior medical imaging. We reinvented ultrasound technology by creating the world’s first handheld, single-probe whole-body ultrasound system: the Butterfly iQ. This breakthrough technology reduces the cost of the traditional ultrasound system by miniaturizing it onto a single semiconductor silicon chip. Butterfly harnesses the
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant Health has commercially launched Guardant360®,
Insitro aims to improve the drug discovery process. Founded by machine-learning veteran Daphne Koller, it creates in vitro models of human disease in its automated laboratory and then applies machine-learning models to predict possible effective therapies. It recently announced a partnership with drug maker Gilead Sciences, worth up to $1 billion, to help it find
